Influence of Zr and V dopants on the degree of the Ti3SiC2 MAX phase formation by mechanochemistry
Physics and Chemistry of Solid State · 21.08.2026 · 27 (3) · 463-467
DOI: 10.15330/pcss.27.3.463-467 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physics and Chemistry of Solid State, online erschienen am 21.08.2026. Verfasst von D.S. Korablov und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
As a result of mechanically activated self-propagating synthesis, from the initial mixture of Ti, Si, and C powders or a mixture of Ti, Si, and C powders with the addition of 5 wt. % Zr or with the addition of 5 wt. % V, the MAX phase Ti3SiC2 was obtained. The effect of doping the MAX phase Ti3SiC2 with zirconium and vanadium on the degree of its formation was investigated. It was found that doping the MAX phase Ti3SiC2 with 5 wt. % V led to an increase in its amount and, accordingly, a decrease in the amount of the secondary TiC phase in the final product. When doping the MAX phase with 5 wt. % Zr, on the contrary, its amount decreased, and the amount of the TiC phase increased.
Zitieren
APA
Korablov, D., Ershova, O., Koval, O., Коpаn, А., & Solonin, Y. (2026). Influence of Zr and V dopants on the degree of the Ti3SiC2 MAX phase formation by mechanochemistry. Physics and Chemistry of Solid State, 27(3), 463-467. https://doi.org/10.15330/pcss.27.3.463-467
Vancouver
Korablov D, Ershova O, Koval O, Коpаn А, Solonin Y. Influence of Zr and V dopants on the degree of the Ti3SiC2 MAX phase formation by mechanochemistry. Physics and Chemistry of Solid State. 2026;27(3):463-467. doi:10.15330/pcss.27.3.463-467
BibTeX
@article{Korablov2026,
author = {Korablov, D.S. and Ershova, O.G. and Koval, O.Yu. and Коpаn, А.R. and Solonin, Yu.M.},
title = {Influence of Zr and V dopants on the degree of the Ti3SiC2 MAX phase formation by mechanochemistry},
journal = {Physics and Chemistry of Solid State},
year = {2026},
volume = {27},
number = {3},
pages = {463--467},
doi = {10.15330/pcss.27.3.463-467}
}
EUVIMED